An observational study in Frailty, sponsored by Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2020-11-04.
Sponsored by Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 83 studies in Frailty with a site in Turkey — 24 open to participants now, 27 under way, none of them phase 3. Frailty · Turkey.
Among the 83 studies in Frailty with a site in Turkey, this one is the 25th largest by enrollment of the 67 observational ones that give a count, is one of 6 that started in 2020, is one of 67 observational ones, and was the 4th registered.
1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.
Browse Frailty studies →24 of the 83 studies in Frailty with a site in Turkey are open now. Recruiting first, the newest first:
Konya City Hospital · Sites in Turkey
Ages 65+
Kocaeli City Hospital · Sites in Turkey
Ages 65+
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
Konya City Hospital · Sites in Turkey
Ages 18+
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Sites in Turkey
Ages 65–70
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
83 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 6 started in 2020.
This study's enrollment of 164 is below the median of 225 across 495 observational studies indexed under Frailty.
Median enrollment 64 across the 16 interventional studies, 138 across the 67 observational. Of the 51 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 83 has an industry lead sponsor. The 10 most frequent:
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital is the lead sponsor of 5 studies on the registry; none are open to participants now.
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital has 1 study filed under Frailty — fewer than ten, so there is no comparison to draw.
12 of the studies in Frailty with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07813702MERT UYSALURINARY INCONTINENCE AND GERIATRIC SYNDROMES | 2026-11 |
| NCT07677072Kanuni Sultan Suleyman Training and Research HospitalCan Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women? | 2026-12-01 |
| NCT07463352Duzce UniversityPreoperative Oral Nutrition And Outcomes In Frail Elderly Patients With Femur Fractures | 2027-01-01 |
| NCT07458048Istanbul University - CerrahpasaComparıson of the Effıcacy of Conventıonal Exercıse and Pılates ın Pre-fraıl and Fraıl Older Adults | 2027-02 |
| NCT07642765Konya City HospitalEASIX Score and Post-Induction Hypotension in Frail Patients Undergoing Non-Cardiac Surgery | 2027-02-01 |
Add all 12 to your calendar (.ics) → With an account.
Among the 83 studies in Frailty with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
With increasing life expectancy, cardiac surgical procedures are increasingly being performed in older adults. The biological syndrome of frailty is an aging-associated state with diminished physiological reserve and resistance to stressors, such as major surgery. In the European System for Cardiac Operative risk Evaluation (EuroSCORE II) and the Society of Thoracic Surgeons (STS) risk scoring systems, patient comorbidities including advanced age and poor mobility are considered as risk factors for operative mortality. However, an objective assessment of frailty is not included. Traditionally, frailty assessment before cardiac surgery is primarily performed based on surgeon's subjective perception of patient's general appearance. Objective measurement of frailty is increasingly being applied as a routine part of preoperative evaluation of elderly patients undergoing cardiac surgery. The most widely used frailty assessment tool is the Fried scale. The investigators aim to investigate whether Fried scale would predict operative mortality and morbidity in elderly patients undergoing elective cardiac surgery.
Consecutive patients who are scheduled to undergo elective cardiac surgery in Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital will be evaluated for enrollment. Those who meet inclusion and exclusion criteria will be invited to be study participants. Volunteers will constitute the study population. All participants will undergo routine preoperative risk assessment procedures of our institution, which include history, physical examination, blood chemistry, chest X-ray, echocardiogram, and spirometry. As part of this routine assessment, Fried scale (5-meter walk test, hand-grip strength, questioning of weight loss, short version of the Center for Epidemiological Studies-Depression scale, and short version of the Minnesota Leisure Time Physical Activity questionnaire) will be applied to all participants. Demographics characteristics and clinical data will be observed and recorded. Participants will be divided into 3 groups according to Fried scale; frail, moderately frail, and not frail.
In order to investigate the ability of Fried scale to predict cardiac operative mortality and morbidity, groups will be compared in terms of surgical mortality, renal failure, stroke, prolonged mechanical ventilation, deep sternal wound infections, re-operation, prolonged length of stay, and readmission rates.
Power analysis was performed to estimate sample size using G*Power (v3.1.7) software. A total 150 participants are needed in order to achieve an 80% (Beta=0.2) power at the 5% (Alpha=0.05) level of significance.
Categorical data will be presented as frequency and percentage. Continuous variables will be presented as mean [±standard deviation] and median [interquartile range]. Categorical variables will be compared using chi-square and Fisher's exact tests. Kolmogorov-Smirnov test will be used to assess distribution of continuous variables. Continuous variables with a normal distribution will be compared using Student's t-test, and those with a non-normal distribution will be compared using Mann-Whitney U test.
SPSS for Windows v.17.0 (SPSS Statistics Inc., Chicago, Ill., USA) will be used for all statistical analyses. A two-sided p value of \<0.05 will be considered to be statistically significant.
Patients scheduled to undergo elective cardiac surgery in Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants with 3 or more components of Fried frailty scale
Participants with 1-2 components of Fried frailty scale
Participants without any components of Fried frailty scale
Number of Participants with Operative Mortality or Major Morbidity
Composite endpoint defined by The Society of Thoracic Surgeons. Operative mortality is defined as death occurring within 30 days after surgery, or during the same hospitalization following surgery. Major morbidity includes permanent stroke, renal failure, prolonged ventilation, deep sternal wound infection, re-operation for any reason.
Time frame: 30 days
Number of Participants with Prolonged Length of Stay
Failure to be discharged within 14 days of surgery
Time frame: 14 days
Number of Participants with Prolonged Length of Intensive Care Unit Stay
Length of intensive care unit stay ≥ 48 hours
Time frame: 48 hours
Number of Participants with Readmission to Intensive Care Unit
Unplanned readmission to intensive care unit during index hospitalization
Time frame: 30 days
Number of Participants with Readmission to hospital
Rehospitalization for any reason within 30 days of discharge
Time frame: 30 days
Plan to share: No
Ran from Jan 2020 to primary completion in May 2020, 4 months.
Of 291 non-industry observational studies under Frailty, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's 4 months is below that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 12 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital